Aim: Testosterone treatment is essential for the induction and maintenance of virilization of female-to-male transsexuals. This study tested the suitability of a novel testosterone preparation for this purpose.
Methods: Parenteral long-acting testosterone undecanoate (TU) was administered to 12 female-to-male transsexuals. Observations were made while subjects received treatment.
Main Outcome Measures: Virilization of female-to-male transsexuals and side effects of testosterone administration.
Results: The testosterone levels were largely identical to those in hypogonadal men receiving testosterone treatment with TU. There were no side effects. There was a small but significant decrease in plasma cholesterol and low-density lipoprotein, but plasma high-density lipoprotein did not change significantly. Both levels of hemoglobin and hematocrit rose upon administration but remained within the physiological range.
Conclusions: TU is suited for induction of virilization in female-to-male transsexuals without significant side effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1743-6109.2007.00556.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"Escaping the Gender Prison"-Transgender Men's Experience Before and After Hysterectomy: A Qualitative Study.
J Homosex
July 2024
Faculty of Medicine, Department of Obstetrics and Gynecology, Düzce University, Düzce, Türkiye.
This study aimed to examine the experiences of female-to-male transgendered individuals (FtMs) who underwent gender-affirming hysterectomy (GAH) and to investigate patients' perceptions of GAH and their expectations and support needs from healthcare professionals before and after the surgery. The study used a phenomenological approach and a qualitative research method. Data were collected through in-depth interviews.
View Article and Find Full Text PDFTestosterone and other treatments for transgender males and non-binary trans masculine individuals.
Best Pract Res Clin Endocrinol Metab
September 2024
Department of Endocrinology, Gender Identity Clinic, Tavistock & Portman NHS Foundation Trust, London, UK; St George's University of London Medical School, UK. Electronic address:
Article Synopsis
- Testosterone therapy is the primary treatment for transmen to help with gender dysphoria, promoting physical masculinization and enhancing quality of life.
- The paper discusses methods of testosterone administration, effects on body systems, health risks, and the importance of ongoing monitoring.
- Continued research on varying testosterone dosages, pregnancy considerations, and older transmen can further optimize treatment approaches.
Sheikhmoonesi, F. (2024) "Male-to-female and female-to-male transsexual siblings with pedophilic father: A case report" , 12: e8580. https://doi.
View Article and Find Full Text PDFWithdrawn: Male-to-female and female-to-male transsexual siblings with pedophilic father: A case report.
Clin Case Rep
March 2024
Psychiatry and Behavioral Sciences Research Center Addiction Institute, Mazandaran University of Medical Sciences Sari Iran.
Sheikhmoonesi, F. (2024) "Male-to-female and female-to-male transsexual siblings with pedophilic father: A case report" , 12: e8580. https://doi.
View Article and Find Full Text PDFThe Most-Cited Publications in Gender-Affirming Surgery: A Cross-Sectional Bibliometric Analysis.
Plast Surg (Oakv)
February 2024
New York-Presbyterian Hospital, New York, NY, USA.
Gender-affirming surgery is becoming more common among reconstructive surgeons. Bibliometric analyses are statistical evaluations of published scientific correspondence and are a validated method of measuring influence in the scientific community. As no such bibliometric analysis has been done as of yet, the purpose of this study is to identify the characteristics of the 50 most-cited peer-reviewed articles on gender-affirming surgery.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!